Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of combination of sorafenib and oleanolic acid in preparation of medicine for treating liver cancer

An oleanolic acid, a technology for treating liver cancer, applied in the field of medicine, can solve the problems of SOR toxicity, easy to produce drug resistance, etc.

Inactive Publication Date: 2020-10-20
JIAMUSI UNIVERSITY
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to the toxicity of SOR and the problem of easy drug resistance, it is also subject to certain restrictions in the application process.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of combination of sorafenib and oleanolic acid in preparation of medicine for treating liver cancer
  • Application of combination of sorafenib and oleanolic acid in preparation of medicine for treating liver cancer
  • Application of combination of sorafenib and oleanolic acid in preparation of medicine for treating liver cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Example 1 BEL-7402 cell culture

[0042] BEL-7402 was cultured with RPMI 1640 medium containing 10% fetal bovine serum (FBS), 100×L-glutamine (L-Glu), and 100×HEPES. Routinely take 400,000 BEL-7402 cells in the logarithmic growth phase and inoculate them in a 60mm plate, 3ml system, and pass them every 2 days. When passaging, first remove the old medium, and then use 1:1 diluted trypsin digestion solution (Trypsin-EDTA 0.25% to HBSS volume ratio 1:1). After 1ml digestion for 2 minutes, discard the trypsin digestion solution and add 1ml fresh culture Base, gently blow down the adherent cells to mix evenly, passaging 1:4 to 1:5.

Embodiment 2

[0043] Example 2 Cell Proliferation Inhibition Experiment

[0044] In order to observe whether the combination of SOR and OA has a synergistic effect, the BEL-7402 cells prepared in Example 1 were used for different administration treatments, and the cell proliferation activity was detected by the CCK-8 method, and the proliferation of BEL-7402 cells was inhibited by the action of drugs In order to judge the efficacy of the combined application of the two drugs. The specific operation is as follows:

[0045] (1) Plating: Specify the total system of 200μl / well in a 96-well plate. The BEL-7402 cells in the logarithmic growth phase were seeded in a 96-well plate (1000 cells / well, 100 μl cell suspension), and incubated overnight at 37°C until the cells adhered.

[0046] (2) Dosing treatment: set the empty well group (only containing 100μl of medium), blank control group (BEL-7402 cells, medium), solvent control (BEL-7402 cells, medium, solvent, the solvent is the volume 1:1 ratio of D...

Embodiment 3

[0062] Example 3 Experiment on the influence of cell cycle

[0063] SOR and OA were used in combination to act on BEL-7402 cells, and flow cytometry was used for analysis to determine the effect of the combination of the two drugs on the cell cycle progression of BEL-7402.

[0064] (1) Preparation of cell samples to be tested

[0065] (1) Inoculate BEL-7402 cells in logarithmic growth phase in a 6-well plate, 200,000 per well, 2ml culture system, and culture at 37°C for 24 hours.

[0066] (2) SOR (2,4,10μM), OA (2,5,10μM) and SOR 4μM are used in combination with OA (2,5,10μM) respectively. The maximum amount of working solution is 1ml, and each is prepared (2×)10μM SOR and (2×)10μM OA working liquid were administered sequentially in gradients, and 2ml of the total system was supplemented with culture medium (same as Example 1) so that the final concentration of working liquid in each well after administration was set as above. Constant temperature treatment at 37°C for 24h.

[0067] (...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pore sizeaaaaaaaaaa
Login to View More

Abstract

The invention discloses an application of a combination of sorafenib and oleanolic acid in preparation of a medicine for treating the liver cancer, and belongs to the technical field of medicines. Compared with the prior art, the application has the beneficial effects that a relationship between the synergistic effect of OA on SOR and an mTOR signal channel is proposed for the first time, the action concentration of the OA and SOR combination is greatly reduced, the problem of drug resistance of the SOR is solved, the economic burden of a patient is relieved, the lifetime of the patient is prolonged, and a new direction is provided for clinical treatment of the liver cancer.

Description

Technical field [0001] The present invention relates to the technical field of medicine, and more specifically to the application of sorafenib combined with oleanolic acid in the preparation of drugs for treating liver cancer. Background technique [0002] Hepatocellular carcinoma (HCC) is an important histological type of liver cancer. There are significant differences between Chinese liver cancer patients and Western countries in terms of the cause, biological behavior, clinical characteristics, treatment options and prognosis. Therefore, it is very important to actively explore treatment strategies suitable for HCC in Chinese, and to select and apply rationally to further improve the overall efficacy of advanced liver cancer. [0003] Sorafenib (SOR), a multi-kinase inhibitor, is a drug that can significantly prolong the survival of patients with advanced HCC, and the median survival of patients can be extended by an average of 3 to 5 months. The SOR target is located in the R...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/56A61K31/44A61P35/00A61P1/16
CPCA61K31/56A61K31/44A61P35/00A61P1/16
Inventor 朴金花伊芯王迪迪张鹏霞葛堂栋商宇宋琳琳裴思莹
Owner JIAMUSI UNIVERSITY